Shubh Goel
Vice President, Head of Immuno-Oncology and Gastrointestinal (GI) Tumors Franchise, US Oncology Business Unit
Responsibilities
As the VP, Head of Immuno-Oncology and GI Tumors Franchise for US Oncology at AstraZeneca, Shubh Goel oversees all sales, marketing, and cross-functional team efforts across the Immuno-Oncology portfolio of indications and GI sales teams.
Prior Experience
Prior to joining AstraZeneca, she was Chief Commercial Officer of Fennec, a late-stage biotechnology company dedicated to improving the lives of children with cancer. She also held various commercial and marketing leadership positions at Odonate Therapeutics, Celgene, Bayer AG, Aveo Oncology, Ariad Pharmaceuticals, and Millennium Pharmaceuticals.
Education
- Bachelor of Science degree in Biochemistry from the University of Bath
Our leadership, which includes our Board of Directors and Senior Executive Team represents the interests of all our stakeholders in ensuring that we deliver for patients by putting science at the heart of everything we do.
Stories from our people and our partners reveal the passion, energy and knowledge that enable us to put science at the heart of everything we do.
We are a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
Join AstraZeneca
and help us deliver life-changing medicines
Be among our employees who continue to make us an innovation-driven company that stands firmly among the world’s leaders in biopharmaceuticals.